Paper · 2025 · Open access
Exploring the Role of Pharmacogenomics in Personalized Medicine: A Pathway to Tailored Drug Therapy
Zenodo (CERN European Organization for Nuclear Research) · Published 20 December 2025 · DOI 10.5281/zenodo.17996542
In brief
“Exploring the Role of Pharmacogenomics in Personalized Medicine: A Pathway to Tailored Drug Therapy” is a 2025 paper by Muhammad Ammar Nawaz2* Fizza Salik1, published in Zenodo (CERN European Organization for Nuclear Research). OpenAlex counts 0 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at Zenodo (CERN European Organization for Nuclear Research).
- Citations
- 0
- Authors
- 1
Abstract
Pharmacogenomics, the study of how genetic variations affect individual responses to drugs, is a critical component of personalized medicine. This field has emerged as a key area of research in optimizing drug therapy, providing a pathway for individualized treatment plans based on genetic profiles. The potential of pharmacogenomics to enhance therapeutic efficacy, minimize adverse drug reactions, and improve overall patient outcomes has revolutionized the field of medicine. With the advancements in genomic technologies, pharmacogenomics is now increasingly integrated into clinical practice. By identifying genetic variations that influence drug metabolism, transport, and target interactions, healthcare professionals can tailor drug therapies to maximize benefits and reduce the risk of harmful side effects. The integration of pharmacogenomics into clinical settings promises significant improvements in drug safety and efficacy, particularly for patients with complex medical conditions such as cancer, cardiovascular diseases, and psychiatric disorders. However, several challenges remain, including the high costs of genomic testing, limited access to genetic data, and the need for continued research to establish guidelines for clinical implementation. This paper explores the role of pharmacogenomics in personalized medicine, reviewing its potential to transform healthcare by providing more targeted and effective therapies.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Salik1, M. A. N. F. (2025). Exploring the Role of Pharmacogenomics in Personalized Medicine: A Pathway to Tailored Drug Therapy. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.17996542
MLA 9
Salik1, Muhammad Ammar Nawaz2* Fizza. “Exploring the Role of Pharmacogenomics in Personalized Medicine: A Pathway to Tailored Drug Therapy.” Zenodo (CERN European Organization for Nuclear Research), 2025. https://doi.org/10.5281/zenodo.17996542.
Chicago
Salik1, Muhammad Ammar Nawaz2* Fizza. 2025. “Exploring the Role of Pharmacogenomics in Personalized Medicine: A Pathway to Tailored Drug Therapy.” Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.17996542.
Harvard
Salik1, M. A. N. F. (2025) ‘Exploring the Role of Pharmacogenomics in Personalized Medicine: A Pathway to Tailored Drug Therapy’, Zenodo (CERN European Organization for Nuclear Research). doi:10.5281/zenodo.17996542.
IEEE
M. A. N. F. Salik1, “Exploring the Role of Pharmacogenomics in Personalized Medicine: A Pathway to Tailored Drug Therapy,” Zenodo (CERN European Organization for Nuclear Research), 2025, doi: 10.5281/zenodo.17996542.
BibTeX
@article{salik12025exploring,
title = {{Exploring the Role of Pharmacogenomics in Personalized Medicine: A Pathway to Tailored Drug Therapy}},
author = {Salik1, Muhammad Ammar Nawaz2* Fizza},
journal = {Zenodo (CERN European Organization for Nuclear Research)},
year = {2025},
doi = {10.5281/zenodo.17996542},
url = {https://doi.org/10.5281/zenodo.17996542}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- pharmacogenomics
- personalized medicine
- genetic variation
- drug metabolism
- adverse drug reactions
- drug safety
- drug efficacy
- clinical implementation
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Salik1, M. A. N. F. (2025). Exploring the Role of Pharmacogenomics in Personalized Medicine: A Pathway to Tailored Drug Therapy. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.17996542
How many times has this paper been cited?
0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Zenodo (CERN European Organization for Nuclear Research): sign in and open the full text from this page.
Who wrote this paper?
Muhammad Ammar Nawaz2* Fizza Salik1.
What is the DOI of this paper?
10.5281/zenodo.17996542, permanently at https://doi.org/10.5281/zenodo.17996542. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.